Structural Basis for Functional Tetramerization of Lentiviral Integrase by Hare, Stephen et al.
Structural Basis for Functional Tetramerization of
Lentiviral Integrase
Stephen Hare
1, Francesca Di Nunzio
2, Alfred Labeja
1, Jimin Wang
3, Alan Engelman
2*, Peter
Cherepanov
1*
1Division of Medicine, St. Mary’s Campus, Imperial College London, London, United Kingdom, 2Department of Cancer Immunology and AIDS, Dana-Farber Cancer
Institute, Boston, Massachusetts, United States of America, 3Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, United
States of America
Abstract
Experimental evidence suggests that a tetramer of integrase (IN) is the protagonist of the concerted strand transfer reaction,
whereby both ends of retroviral DNA are inserted into a host cell chromosome. Herein we present two crystal structures
containing the N-terminal and the catalytic core domains of maedi-visna virus IN in complex with the IN binding domain of
the common lentiviral integration co-factor LEDGF. The structures reveal that the dimer-of-dimers architecture of the IN
tetramer is stabilized by swapping N-terminal domains between the inner pair of monomers poised to execute catalytic
function. Comparison of four independent IN tetramers in our crystal structures elucidate the basis for the closure of the
highly flexible dimer-dimer interface, allowing us to model how a pair of active sites become situated for concerted
integration. Using a range of complementary approaches, we demonstrate that the dimer-dimer interface is essential for
HIV-1 IN tetramerization, concerted integration in vitro, and virus infectivity. Our structures moreover highlight adaptable
changes at the interfaces of individual IN dimers that allow divergent lentiviruses to utilize a highly-conserved, common
integration co-factor.
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Introduction
To establish productive infection, a retrovirus must insert the
reverse-transcribed form of its genome into a host cell chromo-
some. This process critically depends on two reactions, 39-
processing and strand transfer, catalyzed by the viral enzyme
integrase (IN) (reviewed in [1]). During 39-procesing, IN
endonucleolytically removes two or three nucleotides from the
39-termini of viral DNA to expose 39-OH groups of invariant CA
dinucleotides. These are subsequently utilized in a pair of
coordinated transesterification reactions, resulting in the insertion
of both viral DNA termini across the major groove of
chromosomal DNA. Integration is completed through the action
of host DNA repair enzymes, which mediate the necessary joining
of viral DNA 59-ends, yielding a short duplication of target DNA
sequence flanking the integrated provirus.
Retroviral INs have a characteristic three-domain organization,
all containing N-terminal, catalytic core and C-terminal domains
(NTD, CCD, CTD) (reviewed in [2]). The CCD contains the
invariant D,D-35-E motif responsible for coordination of two
Mg
2+ ions within the active site and accounts for sequence-specific
interactions with viral DNA [3,4]. The positively-charged CTD is
also implicated in DNA binding, likely accounting for sequence-
independent interactions [5]. All three domains contribute to IN
multimerization [6–8]. CCDs of divergent retroviral INs invari-
ably crystallize as dimers, with isomorphous dimer interfaces [9–
11]. Structures of the NTD and CTD have been solved both alone
and as part of two-domain constructs involving the CCD by
respective use of NMR and crystallography [12–15]. The NTD
forms a three-helical bundle stabilized through coordination of a
Zn
2+ ion by the invariant HHCC motif. The CTD consists of a
five-stranded b-barrel similar to Src homolgy 3 domains.
Althoughthestructureoffull-lengthretroviralINremainselusive,
its partial structures wereinstrumental in unraveling the mechanism
of integration. The near-spherical CCD dimer cannot alone explain
the concerted integration of two viral DNA ends. Indeed, the active
sites, located on opposite sides of the dimeric CCD structure, are
separatedby,40 A ˚,whilethedistancebetweentargetscissilebonds
in ideal B form DNA is close to 18 A ˚. A tetramer would be the
minimal IN multimer to provide a pair of active sites with the
expected spacing, and available experimental evidence suggests that
thefunctional formofretroviralINisindeedtetrameric [16–19].An
attractive model was derived from the crystal structure of a two-
domain fragment of HIV-1 IN (INNTD+CCD) [15]. Although lacking
the CTD, this construct crystallized in tetrameric form, best
described as a dimer-of-dimers, with the dimers interacting with
each other predominantly via NTD-CCD contacts. This model was
inviting because it showed some structural similarity to the synaptic
complex of the related Tn5 transposase [20] and, while the ,29 A ˚
separation of active sites was too far to accommodate concerted
integration,itseemedplausiblethatflexibilityalongthedimer-dimer
interface could provide the necessary geometry.
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on lens epithelium derived growth factor (LEDGF) [21–23]
(reviewed in [24]), a cellular chromatin-associated protein
implicated in transcription regulation and apoptosis [25,26].
LEDGF directly interacts with lentiviral IN proteins and is
thought to tether the preintegration complex to chromatin for
strand transfer [27–29]. The CCD of HIV IN is the main
determinant for the interaction with LEDGF, although the NTD
is required for high-affinity binding [28,30]. Reciprocally, a small
alpha-helical domain within the C-terminal portion of LEDGF is
necessary and sufficient for the interaction with IN [31,32]. Crystal
structures of the integrase-binding domain (IBD) of LEDGF
(LEDGFIBD) in complex with HIV-1 INCCD and HIV-2
INNTD+CCD have revealed molecular details of this interaction
[30,33].
Herein we present two new crystal structures containing the
NTD and the CCD of maedi-visna virus (MVV) IN in complex
with LEDGFIBD. In both structures, this highly divergent lentiviral
IN is present in tetrameric forms, stabilized by swapping pairs of
NTDs between interacting dimers. Comparison of four indepen-
dent IN tetramers observed in our structures reveals variability of
the dimer-dimer interface, which affords juxtaposition of a pair of
active sites for concerted integration. Using a range of comple-
mentary functional assays, we show that the tetramerization
interface is essential for IN function, both in vitro and in the
context of viral replication.
Results
Crystal structures of the MVV INNTD+CCD:LEDGFIBD
complex
To ascertain protein-protein interfaces involved in retroviral
integration, we sought to determine crystal structures of divergent
lentiviral INs. MVV IN presented an appealing target because it
shares less than 30% overall sequence identity with its HIV-1
counterpart (Figure S1). Opportunely, sequence analysis of
LEDGF cDNA isolated from sheep, a natural MVV host,
confirmed that the amino acid sequence of its IBD is identical to
that of the human ortholog. Bacterial co-expression of MVV
INNTD+CCD (residues 1–219) with LEDGFIBD yielded monodis-
perse preparations of the protein-protein complex without
introducing solubilizing point mutations into the IN construct.
The protein complex crystallized in two forms, referred to as
crystal form (CF) 1 and CF2, and the resulting structures were
refined to 3.28 and 2.64 A ˚, respectively (Table 1).
The asymmetric unit (ASU) of CF1 contains three IN dimers
(chains A–F), each with a pair of associated LEDGF chains (G–L).
The dimers interact with each other to form three independent
dimer-dimer interfaces, such that the EF dimer interacts with the
AB and CD dimers, and the CD dimer with the A9B9 dimer from
another ASU (Figures S2A–S2C). The ASU of CF2 contains a
pair of IN dimers that form a single tetramer with four associated
LEDGF chains (Figure S2D). Although in most IN chains the
loops connecting NTDs and CCDs are disordered, clear electron
density was seen in chain B of CF1, allowing unambiguous
assignment of all NTDs in this crystal form (Figure S2C). In CF2,
where the NTD-CCD linkers are disordered for all monomers,
unambiguous assignment of IN chain B and C NTDs (cyan and
yellow in Figure S2D) was possible due to distance restraints: the
shortest path to connect chain B Gln44 with chain C Ser55, while
avoiding clashes with the rest of the model, would be well over
50 A ˚, a distance that cannot be covered by 10 amino acid residues.
IN tetramerization is primarily mediated by
intermolecular NTD-CCD interactions
Collectively, CF1 and CF2 reveal four independent IN
tetramers (Figure S2). Within each tetramer a pair of NTDs
(henceforth referred to as inner NTDs) mediate stable dimer-
Table 1. Summary of crystallographic statistics.
CF1 CF2
Data collection:
Resolution range
a (A ˚) 40-3.28 (3.46-3.28) 40-2.64 (2.71-2.64)
Rmerge
a 11.0 (66.5) 10.2 (58.6)
Multiplicity
a 3.8 (3.8) 3.4 (3.3)
I/sI
a 11.2 (2.0) 8.1 (2.1)
Completeness
a (%) 99.6 (99.7) 99.5 (99.4)
Refinement:
Resolution (A ˚) 40-3.28 40-2.64
Reflections work set 32,366 50,264
Reflections test set 1,718 2,827
Rwork (%) 21.28 22.63
Rfree (%) 25.51 25.30
No. protein atoms 12,786 8,625
No. ligand/ion atoms 6 43
No. water molecules 0 110
R.m.s. bonds (A ˚) 0.009 0.013
R.m.s. angles (u) 1.134 1.406
Ramachandran plot (%):
Favored 93.6 96.6
Allowed 5.2 3.2
Outliers 1.2 0.2
aData in parentheses represent highest resolution shell.
doi:10.1371/journal.ppat.1000515.t001
Author Summary
Integrase is the viral enzyme that orchestrates insertion of
both ends of retroviral DNA into a host cell chromosome.
This process, thought to require a tetramer of integrase,
involves two concerted cutting/joining (transesterification)
reactions that target a pair of phosphodiester bonds in
chromosomal DNA, separated by ,18 A ˚. Until now, the
architecture of the integrase tetramer responsible for
concerted integration has remained a mystery. We now
report two crystal structures containing the N-terminal and
catalytic core domains from a lentiviral integrase in
complex with its co-factor LEDGF. Comparison of the
structural arrangements observed in our crystals elucidates
the details of the integrase tetramerization interface,
reveals its dramatic flexibility and the mechanism by
which a pair of active sites can be brought into close
proximity. Taking advantage of the structural data, we
generated a series of HIV-1 integrase mutants designed to
disrupt or re-create its tetramerization interface. Biochem-
ical and virus replication studies with these mutants
strongly support the functional significance of the
tetrameric architecture observed in the crystal structures.
Our results provide important novel insights into the
assembly of the functional integrase tetramer and will be
invaluable for the ongoing efforts to model the retroviral
pre-integration complex.
Functional Integrase Tetramerization
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conserved role or position within the tetramers (Figure S2). The
salient details of higher-order dimer-dimer interaction are shown
for three of the four tetramers (CF1/IN chains CDEF, CF1/
ABEF, and CF2/ABCD) in Figure 1A–1C, with LEDGF chains
and outer NTDs omitted for clarity. The interface within the
CF1/CDA9B9 tetramer is very similar to that in ABEF, and will
therefore not be discussed separately. Within tetramers, the
positions of the inner NTDs relative to the opposing CCD dimers
are maintained in all cases, and are identical to those seen in the
earlier tetrameric HIV-1 (Figure 1D) and dimeric HIV-2
INNTD+CCD structures, although in the latter case the NTD-
CCD interfaces were intramolecular [15,30].
The NTD-CCD interfaces, observed in the structures of
divergent INs, share conserved features including a well-defined
salt bridge between Glu11 and Lys188 (Lys186 in HIV-1 IN; refer
to Figure S1 for an MVV/HIV-1 IN sequence alignment) and
hydrophobic interactions involving Trp15 (Tyr15 in HIV-1 IN)
and chain A Tyr134 as well as chain B Leu167, Ile183, Thr184
and Lys188 (Trp132, Val165, Phe181, Ile182 and Lys186,
respectively, in HIV-1 IN) (Figure 2A and 2B). An additional salt
bridge is formed between Glu25 and Lys190, and this is
reproduced in the HIV-1 IN interface as Asp25:Lys188. HIV-2
IN encodes Lys at position 25, so it cannot form the same salt
bridge; instead the related Arg188 forms a salt bridge with Glu21
(Figure 2C). The conservation of the NTD-CCD interface and the
resulting tetramers in crystal structures of divergent lentiviral INs
strongly argues for their functional relevance.
Closure of the flexible tetramerization interface
Although each IN tetramer is stabilized by identical intermo-
lecular NTD-CCD interactions, there is remarkable variation in
the relative positions and orientations of the interacting dimers
(Figure 1, Figure S2, Videos S1 and S2). The plasticity of the
dimer-dimer interface is sufficient to allow a pair of active sites
from the opposing CCD dimers in CF2 to approach 14.9 A ˚
separation (measured as the distance between Cc atoms of the
active site Glu residues). For a comparison, the separation
between the structurally-equivalent active sites in CF1/ABEF is
27.5 A ˚, while that in the HIV-1 INNTD+CCD structure [15] is
,29 A ˚ (Figure 1). In addition to the stable intermolecular NTD-
CCD interactions, the tetramerization interface involves a loop
connecting CCD helices a5 and a6 (residues 188–196 and 186–
195 in MVV and HIV-1 respectively, Figure S1), termed finger
[2]. Although rich in Gly residues, the loop adopts a constrained
conformation stabilized by a network of hydrogen bonds, the
aforementioned salt bridges with the NTD, and wields a
hydrophobic residue at the tip (Leu193 in MVV; Ile191 in
HIV) (Figure 2D–2F). Examination of the dimer-dimer interfaces
within individual tetramers reveals profound differences in
relative orientations and contacts made by the fingers of opposing
CCD dimers (Figure 1). Notably, the fingers switch positions
between CF1/CDEF and CF2 structures, with CF1/ABEF
representing an intermediate state (Videos S1 and S2). The most
defined, symmetric and potentially relevant interactions involving
this loop are observed in the CF2 structure, where side chains of
Leu193 residues nucleate a hydrophobic core, engaging Ile200,
Phe203 and Thr195 from the finger of the opposing CCD dimer
(Figure 3A). The chain of hydrophobic contacts propagates to
involve Leu24 and Val20 from the inner NTDs and Ile60 from
the CCD of the same chain and is further stabilized by a well-
defined salt bridge involving Arg58 and Asp18 side chains. These
interactions effectively zip the two halves of the tetramer together,
bringing a pair of active sites from the inner monomers into close
Figure 1. Observed lentiviral IN tetramers. MVV IN tetramers from
CF1 and CF2 structures (A–C), compared to the HIV-1 IN tetramer from
Wang et al. [15] (PDB ID 1k6y) (D). For clarity, the outer NTDs and LEDGF
chains are omitted. The CF1/CDA9B9 tetramer, which is very similar to
CF1/ABEF, is not shown. Protein chains, shown as cartoons, are color-
coded as indicated; cylinders represent a helices. Catalytic triad residues
(Asp66, Asp118 and Glu154 in MVV; Asp64, Asp116 and Glu152 in HIV-1)
belonging to the inner monomers of each tetramer (cyan and yellow
chains) are shown as sticks, the carboxylate oxygen atoms highlighted
as red spheres. The black arrowheads indicate the CCD fingers of the
inner monomers, which participate in tetramerization.
doi:10.1371/journal.ppat.1000515.g001
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PLoS Pathogens | www.plospathogens.org 3 July 2009 | Volume 5 | Issue 7 | e1000515proximity (Videos S1 and S2). A complementary interaction
between the active sites involves a symmetric pair of hydrogen
bonds formed by Gln150 residues of the inner monomers
(Figure 3B). Interestingly, the closure of the tetrameric structure
also subtly modifies the internal configuration of the congregated
active sites. Repulsive dipole-dipole interactions between re-
aligned a4 helices, exacerbated by the close stacking of Arg155
side chains (Figure 3B), result in a slight deformation of both
helices, forcing Glu154 to shift towards Asp66 and Asp118 of the
same active site. For example, the distance between the Ca atoms
of Glu154 and Asp66 decreases from 10.4 A ˚ in the open CF1/
ABEF and CF1/CDEF conformations to 7.7 A ˚ in CF2. The
active site separation in the closed tetramer observed in CF2 is
compatible with the spacing between scissile phosphodiester
bonds in B-form target DNA (Figure 3C). Hence, CF2 represents
an IN tetramer conformation committed for concerted integra-
tion.
The MVV IN-LEDGF interface
Predictably, the overall architecture of the MVV IN-LEDGF
interaction is similar to that described for HIV-1 and HIV-2 INs
[30,33]: it primarily involves the tip of the IBD, notably LEDGF
residues Ile365 and Asp366, and a cleft at the interface of the
CCD dimer. The stoichiometry of MVV INNTD+CCD:LEDGFIBD
complexes observed in both crystal forms is 1:1 (Figure S2), similar
to that in crystals of the HIV-1 INCCD:LEDGFIBD complex [33].
Thus, each MVV IN CCD dimer interacts with a pair of IBDs,
bound at two equivalent positions. All ten CCD:IBD interfaces
observed in CF1 and CF2 structures are very similar. LEDGF
Ile365 forms hydrophobic interactions with Met104, Leu131 and
Figure 2. The NTD-CCD interfaces and CCD finger structures of MVV, HIV-1 and HIV-2 INs. (A–C) The NTD-CCD interface as observed in
MVV INNTD+CCD:LEDGFIBD CF2, HIV-1 INNTD+CCD (PDB ID 1k6y) and HIV-2 INNTD+CCD:LEDGFIBD (PDB ID 3f9k) structures. A cartoon representation is
shown, viewed from the opposite side of the tetramer to Figure 1C, with carbon atoms colored by chain as in Figure 1C and other atoms colored blue
for nitrogen, red for oxygen and yellow for sulfur. Note the interface involving HIV-2 IN is intramolecular in contrast to that in the domain-swapped
tetrameric MVV and HIV-1 IN structures. (D–F) Configurations of the CCD fingers in structures from panels A–C. Side and main chains of the finger
residues are shown as sticks. The color scheme as in panels A–C. Hydrogen bonds are indicated with dashes. Residues discussed in the text are
indicated. Note that Lys185 in the HIV-1 structure in panel E replaces Phe, naturally occurring at this position.
doi:10.1371/journal.ppat.1000515.g002
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second IN chain (Figure 4A). These interactions are related to
those observed for HIV-1, although the actual IN side-chains
involved differ due to lack of sequence identity (Figure S1). As
predicted [27], LEDGF Asp366 duplicates the previously
described bidentate hydrogen bond with backbone amides of
MVV IN residues Asn172 and Ala173 (Glu170 and His171 in
HIV-1).
Lentiviral INs display surprisingly little sequence conservation at
the positions directly involved in the interaction with LEDGF,
itself a well-conserved protein [27,33]. Predictably, some details of
the MVV IN-LEDGF interaction show marked differences with
those elaborated for HIV-1 or HIV-2 INs [30,33] (Figure 4). One
such difference occurs due to MVV encoding residues Arg100 and
Leu131 in place of two Ala residues at HIV-1 IN equivalent
positions 98 and 129. The bulky side-chains pry MVV IN CCD
helices a1 and a3 slightly apart, enlarging the cleft occupied by the
protruding IBD loop. The extra space is filled by the insertion of
LEDGF side chains Asn367 and Leu368, which make hydrogen
bonds with Gln97 and Arg100 and hydrophobic interactions with
Leu130, Leu131 and Tyr134, respectively (Figure 4A). The result
of this alternate binding orientation is a ,34u rotation of the IBD
with respect to the HIV-1 structure, centered at the site of
interaction with the CCD. Consequently, Phe406 and Val408
located on the second loop of the IBD make hydrophobic
interactions with MVV IN Tyr134. Such interactions would not
be possible with HIV-1 IN due to an inevitable steric conflict with
the side chain of Trp131; the equivalent position of MVV IN is
occupied by Lys133, whose flexible side chain makes way for
incoming Phe406 and Val408 (Figure 4). The rotation also allows
LEDGF Lys364 to form a hydrogen bond with the carbonyl group
of MVV IN Pro169 (Figure 4A). In the complex with HIV-1 IN,
Lys364 forms a salt bridge with non-conserved IN residue Glu170.
Additional interactions involving the positive patch on one side of
Figure 3. Details of the IN tetramer consistent with concerted integration. (A) Stereo view on the dimer-dimer interface in CF2, as viewed
from top of the orientation in Figure 1C. The contribution of Leu193, Phe203, Ile200, Thr195, Leu24, Val20, and Ile60 residues from the inner
monomers to the solvent exposed surface in CF2 structure is ,95 A ˚2, compared to ,280 A ˚2 in the open CF1/ABEF tetramer. Relevant side chains are
shown as sticks and indicated. Gray spheres are Zn atoms. Salt bridges involving Arg58 and D18 are indicated with gray dashes. The coloring scheme
is as in Figures 1 and 2. (B) Contacts involving the N-termini of inner monomeric CCD a4 helices. The structure is slightly tilted, compared to the
orientation shown in panel (A). Hydrogen bonds between chain B and C Gln150 residues are shown as gray dashes. Repulsive interaction between
guanidinium groups of Arg155 residues is highlighted with red dashes. (C) A conceptual model for the engagement of target DNA by a closed IN
tetramer. A 17-bp DNA duplex was aligned with the pair of active sites from the inner monomers of the CF2 tetramer. The scissile phosphodiester
bonds are indicated with red triangles, and the separating base pairs are numbered. Secondary structure elements discussed in the text are indicated.
doi:10.1371/journal.ppat.1000515.g003
Functional Integrase Tetramerization
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NTDs are important for high affinity interaction [30]. In CF2,
LEDGF residues Lys401, Lys402 and Arg405 are sufficiently close
for electrostatic interactions with MVV IN Asp41, Glu10 and
Glu9, respectively (not shown). However, the side chains of the
interacting residues are not well defined in electron density maps.
The dimer-dimer interface is critical for HIV-1 IN
tetramerization
To test the relevance of the tetramerization interface observed
in the crystal structures, we designed a series of HIV-1 IN mutants.
The changes were introduced at the positions predicted to be
important for tetramerization by the earlier HIV-1 INNTD+CCD
[15] and current MVV structures. Multimerization properties of
purified proteins were studied using analytical size exclusion
chromatography (SEC) (Figure 5). All proteins displayed non-ideal
behavior, such as temperature-dependent interaction with Super-
dex and silica matrices (data not shown), and generated complex
elution profiles, indicative of multiple multimeric forms. Nonethe-
less, in agreement with previous results [34], the elution profile of
WT HIV-1 IN was consistent with a predominantly tetrameric
species (Figure 5A). Preincubation of IN with an excess of
LEDGFIBD prior to injection resulted in a slightly earlier elution of
the major species (Figure 5B). The peak shift of ,0.15 ml was
consistent with binding of four 10-kDa LEDGFIBD molecules per
IN tetramer. Zinc binding is essential for folding of the NTD and
promotes HIV-1 IN self-association [6,35–37]. Concordantly,
disruption of zinc coordination by the NTD H12N mutation
grossly affected the SEC elution profile (Figure 5A). Under these
experimental conditions, H12N IN behaved as a dimer or a
dimer-monomer mixture.
Remarkably, several mutations at the NTD-CCD interface
affected HIV-1 IN self-association properties to a similar extent as
the NTD-destabilizing H12N mutation. Thus, mutating Tyr15, a
residue involved in several hydrophobic interactions with the CCD
(Figure 2B), abolished multimerization (Figure 5A). Similarly,
disrupting the Glu11:Lys186 salt bridge with single point
mutations E11K or K186E resulted in pronounced shifts to lower
molecular weight species (Figure 5A). Interestingly, less dramatic
shifts were observed for D25K and K188D, suggesting lower
importance of the Asp25:Lys188 interaction for multimerization.
These results agree with an earlier report showing that the K186A
change had a greater effect on tetramerization than did K188A
[34] and are consistent with the crystal structures. Thus, in HIV-1
IN [15], the e-amino group of Lys188 is shared between the
carboxylates of Asp25 and Glu198, separated from either by
,4.6 A ˚ (Figure 2B). In contrast, the e-amino group of HIV-1
Lys186 is only ,3.2 A ˚ from the carboxylate of Glu11, indicating
strong bonding. In MVV IN, the Glu25:Lys190 salt bridge
appears to be the stronger of the two, with the Glu11:Lys188
interaction weakened by interactions between Glu11 and Lys14
(Figure 2A). Remarkably, combining the E11K and K186E
mutations in one protein led to a significant recovery of the higher-
multimeric HIV-1 species, as did mixing equimolar quantities of
single mutants (Figure 5A). Cross-linking with the homobifunc-
tional reagent BS
3 confirmed that WT HIV-1 IN existed as a
predominantly tetrameric species, and that tetramerization was
highly sensitive to the E11K or K186E mutation (Figure S3).
Further corroborating results of the SEC experiments, partial
recovery of tetramer formation was observed in equimolar
mixtures of E11K and K186E mutants (Figure S3). These results
demonstrate that (i) the contact between Glu11 and Lys186 is
essential for the stability of higher-order HIV-1 IN multimers in
vitro and (ii) the salt bridge between these residues can be formed
intermolecularly, corroborating the NTD-CCD connectivity
observed in the MVV structures.
Deletion of residues
190Gly-Ile-Gly
192 from the CCD finger
abrogated multimerization (D190-2, Figure 5C), although the
I191E point mutant multimerized as well as WT (Figure 5C).
Therefore, while the whole of the constrained loop structure is
clearly essential for multimerization, the conserved aliphatic
residue at its tip is not. LEDGF was shown to enhance HIV-1
IN tetramerization [34], an effect likely dependent on the IBD-
NTD interface [30,34]. Accordingly, preincubation with LEDG-
FIBD led to at least partial rescue of multimerization for all NTD-
CCD interface mutants (Figure 5B and 5D). These results are
Figure 4. The LEDGFIBD:INCCD interface. Comparison of IBD:CCD interactions in MVV INNTD+CCD:LEDGFIBD (CF2) (A) and HIV-1 INCCD:LEDGFIBD (PDB
ID 2b4j) (B) structures. The view is from the same side as in Figure S2D. Note the increase in inter helix spacing between MVV CCD a1 and a3, caused
by the replacement of small side-chains (HIV-1 IN residues Ala98 and Ala129) with larger Arg and Leu side-chains (MVV residues 100 and 131,
respectively). The resulting ,34u rotation of the IBD is indicated by the black symbol.
doi:10.1371/journal.ppat.1000515.g004
Functional Integrase Tetramerization
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LEDGF binding is expected to stabilize IN tetramers.
The NTD-CCD interface is vital for IN enzyme activity and
HIV-1 infection
Next, we tested the HIV-1 IN mutants for the ability to catalyze
39-processing and DNA strand transfer using either a blunt-ended
500-bp (Figure 6A), or blunt or pre-processed 23-bp mimic of the
viral U5 DNA end (Figure 6B and 6C). The assay with the longer
viral DNA substrate distinguishes concerted strand transfer
reaction products from those that result from the integration of
a single donor DNA end into only one strand of target DNA,
whereas the oligonucleotide-based assays do not. The Y15A and
D190-2 mutants were almost devoid of 39-processing activity
(Figure 6B), and did not produce strand transfer products in either
assay format (Figures 6A–6C). Interestingly, I191E IN, which
multimerized as well as WT, was attenuated for both 39-processing
(Figure 6B) and strand transfer (Figures 6A and 6C), suggesting
that I191E tetramers might exist in a defective conformation.
Mutants D25K and K188D functioned relatively well in 39-
processing (Figure 6B) and retained near WT strand transfer
activity in the oligonucleotide assay (Figure 6C). However D25K
and, to a lesser degree, K188D, displayed a specific concerted
integration defect, with D25K generating half-site products at near
WT level (Figure 6A).
Mutations E11K and K186E, targeting the Glu11:Lys186 salt
bridge, decreased 39-processing and strand transfer activities
(Figures 6B and 6C) while completely eliminating concerted
integration (Figure 6A, lanes 8–13). The importance of the salt
bridge was further illustrated by the recovery of concerted
integration activity to almost WT levels with the double E11K/
K186E mutant (Figure 6A, lanes 14–16). This result also
confirmed that the mutations do not affect the intrinsic catalytic
properties of the enzyme, or its functional association with donor
or target DNA. Likewise, mixing the two individual mutants
(E11K+K186E), each incapable of forming intramolecular NTD-
CCD interactions, recuperated concerted integration (lanes 17–
19). Consistent with the observation that LEDGF binding aids IN
multimerization (Figures 5B and 5D, see also [34]), the concerted
integration activities of E11K, D25K, K188D, and, to a lesser
extent, K186E, were rescued in the presence of the host factor
(Figure 6D).
IN mutations were next introduced into the single round HIV-
Luc vector, and infectivity was assessed 2 days post-infection.
Based on the results with purified enzymes, E11K, K186E, and
E11K/K186E mutants were initially compared to D64N/D116N
(N/N) active site mutant virus. N/N supported 0.2560.06%
Figure 5. Multimerization of WT and mutant HIV-1 INs. (A) SEC elution profiles of IN proteins versus elution volumes of protein standards
(black arrows). WT (black) and H12N (light gray) IN indicate the tentative volumes of tetramers and dimers, respectively. The profiles of E11K, K186E,
E11K/K186E double, E11K+K186E mixture and Y15A mutants are shown in cyan, red, purple, pink and dark gray, respectively. (B) The elution profiles
of the same mutant INs as in panel A, but pre-mixed with LEDGFIBD prior to chromatography; colors are as in panel A. (C) SEC elution profiles of D25K,
K188D, I191E and D190-2 mutant INs (respectively cyan, red, yellow and green) compared to the profile of WT (black) and H12N (gray) proteins. (D)
Elution profiles of indicated panel C IN proteins in complex with LEDGFIBD.
doi:10.1371/journal.ppat.1000515.g005
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PLoS Pathogens | www.plospathogens.org 7 July 2009 | Volume 5 | Issue 7 | e1000515Figure 6. Enzymatic activities of WT and mutant HIV-1 INs. (A) Concerted integration activity. Three IN concentrations, 0.05, 0.1 and 0.2 mM
(left to right) were used. The migration positions of DNA standards, the donor and the reaction products are indicated. Concerted integration of two
0.5-kb donor DNAs into the circular ,3 kb plasmid target results in a linear ,4 kb product, whereas half-site integration results in a tailed open
circular molecule. The faint band on the gel above the first half site band is likely two half-site integration events into the same target plasmid. The
fuzzy band migrating at ,1 kb is the result of half-site integration of a donor molecule into a second donor. (B) 39-processing and overall strand
transfer activities for each IN mutant, at three different IN concentrations: 0.1, 0.2 and 0.4 mM. Migration of the radiolabeled reactive strand of the
oligonucleotide substrate (23 nt), its processed form (21 nt) and the ladder of the strand transfer products are indicated. (C) Assays conducted in the
same conditions as those in (B) but using pre-processed substrate, which allows the enzyme to by-pass 39-processing. IN was used at 0.2 mM
throughout. (D) LEDGF-dependent concerted integration assay using short, unprocessed (32 bp) oligonucleotides as donor DNA. Lanes 1–3
contained a mock (no protein added) reaction, LEDGF- and donor substrate-omit controls. Concerted integration in this assay results in a product
migrating close to the linearized form of the target DNA, whereas half-site integration a branched form of target DNA, migrating as an open circular
[30]. The smear below the concerted integration product for highly reactive INs is a result of re-targeting of the main product by additional concerted
integration events. Migration of the donor DNA, supercoiled (s.c.) and open circular (o.c.) form of target DNA, and reaction products are indicated.
doi:10.1371/journal.ppat.1000515.g006
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E11K/K186E faired less well, each scoring near the assay
detection limit (,0.025% of HIV-Luc). This suggested that
E11K, K186E, and E11K/K186E might exert class II mutant
behavior: certain mutants, like N/N, are referred to as class I
because they are specifically blocked at integration and accord-
ingly support residual levels of gene expression from unintegrated
DNA, whereas the majority of mutant viruses, class II, display
additional reverse transcription and/or virus assembly defects
[38]. The preliminary assignment of class II mutant behavior is
consistent with the previously reported K186Q reverse transcrip-
tion defect [39,40].
The activities of class II mutant viral enzymes can be analyzed
during infection via trans-incorporation of Vpr-IN fusion proteins
into assembling virus particles [40,41]. Various mutant proteins
were therefore compared to Vpr-INWT for their ability to stimulate
N/N-Luc infectivity. Vpr-INWT enhanced N/N-Luc infection
approximately 6- to 16-fold, yielding overall infectivities that
ranged from 1.4% (Figure 7) to 6.8% (data not shown) of HIV-
Luc. Vpr-INE11K and Vpr-INK186E displayed partial activities,
yielding 3965.8% and 3361.6% of Vpr-INWT function in repeat
(n=5) experiments (Figure 7 and data not shown). Akin to the
result with purified enzymes, the Vpr-INE11K/K186E double
mutant was significantly more active than either single mutant,
actually outshining Vpr-INWT to restore 21.5% of HIV-Luc
activity (Figure 7). Trans incorporation of separate Vpr-INE11K
and Vpr-INK186E single mutants also significantly stimulated N/N-
Luc, yielding 15.7% of overall HIV-Luc infectivity. Importantly,
incorporating the D116A active site mutation into either Vpr-
INE11K or Vpr-INK186E counteracted the stimulatory affect of the
mixture (Figure 7). Immunoblotting revealed similar levels of
functional and non-functional Vpr-IN protein incorporation into
virions (Figure 7).
Discussion
Retroviral INs function as multimers [16–19,41–43]. Due to
obvious structural restraints, such as distances between active sites
in their dimeric CCDs, minimally a tetramer of IN would be
required to carry out concerted integration of both viral DNA
ends. Because a structure of a full-length IN has remained elusive,
much effort is being expended to model a full-length IN tetramer
based on the available partial crystal structures [15,44–46]. In this
work we present two crystal structures containing a two-domain
construct of a divergent lentiviral IN in complex with the isolated
IBD of its natural host cofactor LEDGF. Together with earlier
results [15,30], these structures elucidate the mechanism for IN
tetramerization, indicate the dramatic flexibility of the IN
tetramerization interface (Videos S1 and S2) and for the first time
reveal a tetramer conformation that is compatible with concerted
integration (Figure 3).
It is important to note that the CTD, which is also involved in
IN multimerization [7,47], is not present in our structures.
Figure 7. WT and mutant virus infectivity. The level of N/N active site mutant virus infection, either without added Vpr-IN (left) or with the
indicated Vpr-IN protein(s), as percentage of WT HIV-Luc infectivity. Error bars indicate the variation attained from duplicate experiments (four
independent infections). The western blot below the graph shows total levels of IN, uncleaved Vpr-IN and viral capsid (CA) in pelleted N/N-Luc (lane
1), HIV-Luc (lane 2) or N/N-Luc containing the indicated Vpr-INs (lanes 3–12). Lane 13 contained 3 ng recombinant His6-tagged IN.
doi:10.1371/journal.ppat.1000515.g007
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observed in the crystals using a range of functional assays with
mutants of full-length HIV-1 IN. Herein we demonstrated that the
main proponent of IN tetramerization is the conserved NTD-
CCD interface brought about by swapping a pair of NTDs
between participating IN dimers. We recently showed that within
an IN dimer, the NTDs fold back onto their own CCDs [30]. In
contrast, in the context of a tetramer, interacting IN dimers swap a
pair of NTDs (Figure 1). Although similar connectivity was
postulated earlier [15], hitherto direct evidence for NTD swapping
was not available. The absence of structured NTD-CCD linkers
and the open conformation of the HIV-1 INNTD+CCD tetramer
described by Wang et al. [15] allow various alternative NTD-CCD
connectivities (for more discussion see [30] and [2]). Detailed
analyses of the NTD-CCD interfaces in the current MVV as well
as earlier HIV-1 and HIV-2 IN structures [15,30] revealed a
network of conserved interactions (Figure 2) that are essential for
multimerization (Figure 5). The key interaction involves a
conserved salt bridge, which in HIV-1 IN is mediated by Glu11
and Lys186, and the latter residue has been shown to be important
for HIV-1 IN multimerization [34,48]. Herein we demonstrate
that the Glu11:Lys186 salt bridge is functionally reversible,
allowing us to significantly extend prior observations. Thus, while
individual mutations of both residues abrogated tetramerization
and concerted integration, mixing HIV-1 IN E11K and K186E
single mutants partially recovered tetramerization (Figure 5 and
S3), rescued concerted integration in vitro (Figure 6), and
moreover robustly stimulated N/N-Luc infection (Figure 7). These
results imply that the intermolecular NTD-CCD interface is
functional. The behavior of the E11K+K186E mixture in the virus
complementation assay highlights this functionality. A significant
fraction of inner monomers from the N/N+Vpr-INWT mixture
will contain inactivating D64N/D116N mutations, poisoning
tetramer function. In the N/N+Vpr-INE11K+Vpr-INK186E case,
N/N IN would only be allowed to assume the role of the outer
monomers to accommodate the reversible salt bridge between
inner INE11K+INK186E pairs. Hence the activity of the Vpr-
INE11K+Vpr-INK186E mixture outshines that of Vpr-INWT in this
assay (Figure 7). Furthermore, because the double E11K/K186E
mutant is functional, we can conclude that the mutations do not
affect the intrinsic catalytic properties of the enzyme or its
interactions with DNA. Not only did the double mutant E11K/
K186E recover concerted integration activity and HIV-1 infec-
tion, it also supported greater levels of 39-processing and half-site
integration activities over the individual mutant proteins. This
indicates that while it could be possible for a dimer of IN to
catalyze 39-processing and half-site integration, both reactions are
more efficiently catalyzed by a tetramer (or possibly a larger
aggregate of IN dimers). A similar conclusion was made based on
kinetic studies utilizing a mutant of an alpharetroviral IN that was
unable to form tetramers [49]. Furthermore, this finding is in
agreement with Li and Craigie [50], who observed that 39-
processing and concerted HIV-1 integration are functionally
coupled. We speculate that tetramerization could play a role in the
correct organization of the active site. Indeed, closure of the
tetramerization interface leads to a slight compression of the MVV
IN active site, with active site residue Glu154 relocating closer to
its Asp66 and Asp118 mates. In addition, IN tetramerization and
engagement of the viral DNA termini are likely to be co-
dependent.
Intriguing questions remain as to the nature of the class II
phenotype of HIV-1 IN mutants [38]. Although E11K/K186E
HIV-1 IN was fully competent to carry out concerted integration
starting with blunt ended substrate (Figure 6), the virus carrying
these mutations was not infectious. It is possible that Glu11 and/or
Lys186 impact important noncatalytic IN function(s) at a step prior
to integration, such as reverse transcription [51]. Alternatively, the
mutations might disrupt interaction with a host factor that would
engage the outer IN monomers of the tetramer during integration.
It is important to note that the IN tetramer structure contains two
structurally and functionally-distinct pairs of IN subunits, with the
inner pair (painted cyan and yellow in Figure 1) swapping their
NTDs and providing the active sites, and the other pair (green and
orange) playing a supporting role. Therefore, many residues in the
IN sequence likely have two distinct functions.
The current MVV and the earlier HIV-1 IN [15] structures
(Figure 1), as well as our analyses of the D190-2 mutant, clearly
indicate that the CCD finger is involved in multimerization.
Similarly, alterations within the CCD finger structure impaired
tetramerization of alpharetroviral IN [48]. Truncation of the
constrained loop structure is expected to affect salt bridges
involving HIV-1 Lys186 and Lys188 side chains, and thus the
crucial intermolecular NTD-CCD interface. The significance of
the aliphatic residue at the tip of the finger structure (Ile191 in
HIV-1 or Leu193 in MVV) is highlighted by its conservation in all
lentiviruses. A substitution of HIV-1 IN Ile191 for Glu produced a
protein that was able to multimerize (Figure 5), but was essentially
devoid of enzymatic activity (Figure 6). These results are consistent
with the importance of the aliphatic residue for the formation of
the closed tetramer conformation, represented by the CF2
structure, where a pair of Leu193 residues from opposing CCD
fingers nucleate a hydrophobic core at the dimer-dimer interface
(Figures 1 and 3A).
Superposing partial HIV-1 IN structures onto the CF2 MVV
structure results in a plausible full-length tetrameric model devoid
of significant steric conflicts (Figure S4). Although the majority of
the residues involved in the closure of the dimer-dimer interface
are not conserved between MVV and HIV-1 INs (Figure S1), the
model suggests a potential role of HIV-1 IN residue Tyr194 in
formation of the closed structure via hydrophobic interactions with
Ile191 from the opposing dimer. The conformational variability of
the dimer-dimer interface described here suggests that the
committed IN tetramer is likely stabilized via IN-DNA interac-
tions. It is noteworthy that the synaptic Tn5 transposase:DNA
complex is primarily stabilized via protein-DNA interactions [20].
An earlier model based on the open conformation of HIV-1 IN
tetramer suggested that target DNA would bind into the cleft
between widely separated active sites [15,44]. This implies that the
active sites would approach target DNA duplex from opposing
sides, a configuration not easy to reconcile with the size of target
DNA duplications flanking integrated proviruses. On the other
hand, the closed tetramer conformation would preclude target
DNA access to the interior of the dimer-dimer interface. We
speculate that the target duplex binds roughly along the vector
connecting the active sites, affording them direct access to the
scissile phosphodiester bonds located across the major groove
(Figures 3C and S4). This binding mode is supported by findings of
Katzman and colleagues, who demonstrated that HIV-1 IN
residue Ser119, located within CCD a2, is involved in target DNA
capture [52,53]. More recent results from this laboratory further
confirm a target DNA binding platform extending along this
direction [54]. The locations of the CTDs in the current model
(Figure S4) are compatible with a role in binding viral DNA
termini. It is noteworthy that although the CCD-CTD linker
adopted alpha helical conformation in the structure of the HIV-1
INCCD+CTD fragment [13], similar studies with INs from Rous
sarcoma and simian immunodeficiency viruses [55,56] highlighted
significant flexibility of this region. DNA binding moreover
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CTD linker of HIV-1 IN [57]. Hence positions and orientations of
the CTDs within the tetramer cannot be directly inferred from the
available partial structures.
Because the current MVV (Figure S2) and earlier HIV-1 IN
[15] tetrameric structures disagree on the locations of the outer
NTDs, their roles remain uncertain. In particular, the NTD-NTD
interfaces observed in MVV CF1 tetramers (Figure S2) differ both
from each other and from those observed in HIV-1 INNTD+CCD or
the isolated HIV-1 NTD dimer in solution [12]. These interfaces
likely represent packing artifacts in crystal structures, which
contain continuous chains of dimers linked by tetramerization
interfaces, with the outer NTDs in one tetramer assuming roles of
inner NTDs in another (not shown). In contrast, the tetramer in
CF2 is isolated and does not have NTD:NTD contacts, with the
outer NTDs folding back to lock onto the connected CCDs (Figure
S2D). We expect that the outer NTDs would reveal their role in a
tetramer of full-length retroviral IN or within its complex with
DNA.
Materials and Methods
Recombinant DNA and proteins
The plasmid pCDF-MVV-INNTD+CCD, used for bacterial
expression of non-tagged MVV INNTD+CCD, was made by ligating
a PCR fragment encoding residues 1–219 of IN from molecular
clone KV1772 [58] between NcoI and XhoI sites of pCDF-Duet1
(Novagen). The MVV INNTD+CCD:LEDGFIBD complex, used for
crystallography, was produced and purified essentially as described
previously for HIV-2 INNTD+CCD:LEDGFIBD [30]. Briefly, MVV
INNTD+CCD was co-expressed with His6-SUMO-tagged LEDG-
FIBD in Escherichia coli PC2 cells [27] transformed with pCDF-
MVV-INNTD+CCD and pES-IBD-3C7 [30]. The protein complex,
enriched by absorption to NiNTA agarose (Qiagen), was treated
with SUMO and human rhinovirus (HRV) 14 3C proteases to
release LEDGFIBD from the N-terminal His6-SUMO tag and the
C-terminal flexible tail, respectively. The complex, purified by
SEC on a Superdex-200 column in 1 M NaCl, 50 mM Tris HCl,
pH 7.4, was supplemented with 5 mM DTT, concentrated to 12–
15 mg/ml and stored on ice.
For purification of isolated LEDGFIBD, E. coli PC2 cells
transformed with pES-IBD-3C7 [30] and grown in LB medium
to an A600 of 0.8–1.0 were induced with 0.25 mM isopropyl-thio-
b-D-galactopyranoside at room temperature for 3–4 h. Bacteria
were lysed by sonication in 500 mM NaCl, 0.5 mM PMSF,
20 mM imidazole, 50 mM Tris HCl, pH 7.4, and the pre-cleared
lysate was incubated with NiNTA agarose (Qiagen). The resin was
extensively washed with 20 mM imidazole, 500 mM NaCl,
50 mM Tris HCl, pH 7.4. The protein, eluted in 200 mM
imidazole, 500 mM NaCl, 50 mM Tris HCl, pH 7.4, was
supplemented with 5 mM DTT and SUMO protease (20 mg
protease per mg protein) [30,59] and dialyzed overnight against
cold 250 mM NaCl, 25 mM Tris HCl pH 7.4, 5 mM DTT,
40 mM imidazole. The protease and the released His6-SUMO tag
were depleted by passing the sample through a 5-ml HisTrap
column (GE Healthcare). To remove the disordered C-terminal
tail (residues 436–471) [60], the protein was digested with HRV14
3C protease (20 mg protease per mg protein) at 7uC in the
presence of 10 mM DTT. Minimal LEDGFIBD was then purified
by chromatography through a HiLoad 16/60 Superdex-200
column (GE Healthcare).
To obtain HIV-1 IN mutants, the corresponding changes
were introduced into pCPH6P-HIV1-IN [30] using quick-
change procedure (Stratagene). Full-length LEDGF, HIV-1 IN
and the mutant proteins were produced in bacteria and
purified as previously described [27,30]. All proteins used in
activity assays and analytical chromatography experiments were
tag-free.
Crystallization and structure determination
Hanging drop vapor diffusion crystallization experiments were
conducted at 18uC, mixing 1 ml MVV INNTD+CCD:LEDGFIBD
complex (5 mg/ml in 400 mM NaCl, 2 mM DTT, 20 mM Tris
HCl, pH 7.4) with 1 ml of a reservoir solution. CF1 was
obtained using a reservoir solution of 25–30% (w/v) Jeffamine
M600 (Hampton Research) in 100 mM Bis-Tris propane-HCl,
pH 6.6. The crystals, grown over 5–10 days to a size of
,50650630 mm, were cryoprotected in the reservoir solution
supplemented with 20% (v/v) glycerol and frozen by immersion
in liquid nitrogen. CF1 belonged to space group P21 with unit
cell constants a=91.1 A ˚, b=148.9 A ˚, c=91.1 A ˚, a=c=90u,
b=113.4u. A dataset, collected at 100 K on beamline I04 of the
Diamond Light Source (Oxford, UK), was integrated and scaled
in XDS [61] to 3.28 A ˚ (Table 1). The structure was solved by
molecular replacement using Molrep [62] with three search
models: HIV-1 IN CCD dimer (residues 50–212, from 2b4j),
followed by LEDGF IBD (residues 347–426, 2b4j), and finally
HIV-1 IN NTD (residues 1–43, 1k6y). The resulting model
containing six IN and six LEDGF chains was refined using rigid
body, maximum likelihood and simulated annealing routines as
implemented in Phenix [63] with manual building in Coot [64].
Group isotropic B factors (one per residue) and 6-fold non-
crystallographic symmetry (NCS) were applied throughout;
translation, libration and screw-rotation (TLS) displacements
[65] were accounted for towards the end of the refinement. The
final refined model has good geometry and Rwork/Rfree of 21.3/
25.5% (Table 1).
CF2 was obtained using a reservoir solution containing 0.7–
0.9 M (NH4)2HPO4, 2.5% Jeffamine M600 and 100 mM Bis-Tris
propane-HCl, pH 7.0. Crystals, cryoprotected in the reservoir
solution supplemented with 20% glycerol, were frozen by
immersion in liquid nitrogen, and the data were acquired at
100 K on the Diamond Light Source beamline I02. CF2 belongs
to space group P21 with unit cell constants a=102.7 A ˚,
b=83.0 A ˚, c=115.3 A ˚, a=c=90u, b=101.8u. Diffraction in-
tensity data were corrected for the observed lattice translocation
defect [66]; full details of the detwinning procedure will be
reported elsewhere (S.H., P.C., J.W., submitted for publication).
The structure was solved by molecular replacement, using Molrep
with the MVV IN CCD dimer (from CF1) as a search model,
followed by IBD (from 2b4j) and MVV IN NTD. Two CCD
dimers were found to form a tetramer with four associated NTDs
and IBDs. Following additional cycles of building, TLS and
restrained refinement in Refmac [67] the final model had Rwork/
Rfree of 22.6/25.5% and good geometry (Table 1). Weighted 2Fo-
Fc electron density maps for chain B of CF1 (showing the ordered
NTD-CCD linker) and for three parts of the CF2 structure
(NTD:CCD and IBD:CCD interfaces, as well as the chain B active
site with an associated phosphate ion) are shown in Figure S5.
Transition states between observed conformations of the MVV IN
tetramer (Videos S1 and S2) were simulated using Yale Morph
Server [68]. Protein structure images and animations were
generated using PyMOL software (DeLano, W.L., http://www.
pymol.org). The coordinates and structure factors for CF1 and
CF2 have been deposited in the Protein Data Bank with pdb IDs
3hpg and 3hph, respectively. Raw diffraction images are available
upon request.
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SEC was carried out using a 4.3-ml KW403-4F column
(Shodex) attached to an A ¨KTA Purifier system (GE Healthcare).
The column was immersed in ice and operated at 0.275 ml/min
in 750 mM NaCl, 10 mM MgCl2 and 20 mM HEPES-NaOH,
pH 7.0. Thirty-five ml IN (WT or mutant) diluted to 0.6 mg/ml in
gel filtration buffer supplemented with 25 mM ZnCl2 and 2.8 mM
CHAPS was injected into the column. Where indicated, 0.3 mg/
ml LEDGFIBD was pre-incubated with IN on ice for 5 min prior to
injection.
For cross-linking, 6 ml WT, E11K or K186E IN, or an
equimolar IN mutant mixture (0.54 mg/ml protein in 1 M NaCl,
5 mM DTT, 7.5 mM CHAPS, 25 mM Hepes-NaOH, pH 7.5)
was diluted with 21 ml reaction buffer (0.75 M NaCl, 2 mM
MgSO4,2 5mM ZnCl2, 25 mM Hepes-NaOH, pH 7.5). Cross-
linking was initiated by addition of 4 mlB S
3 (Pierce; fresh 15–
1.7 mM stock in water). Where indicated, reactions were
supplemented with 0.3% SDS prior to addition of the cross-
linking reagent. Reactions, allowed to proceed for 30 min at 18uC,
were stopped by addition of Laemmli SDS PAGE sample buffer.
The products were separated in Novex 10–20% Tricine SDS
PAGE gels (Invitrogen) and detected by staining with Sypro
Orange (Invitrogen).
Integrase enzymatic assays
Oligonucleotide-based 39-processing assays were carried out as
previously described [40]. Briefly, blunt 23-bp DNA substrate was
obtained by annealing 59-end labeled 59-CAGTGTGGAA-
AATCTCTAGCAGT with 59-ACTGCTAGAGATTTTCCA-
CACTG. Reactions (20 ml) contained 0.1–0.4 mM IN, 25 nM
substrate DNA in 20 mM NaCl, 7.5 mM MnCl2, 10% glycerol,
10 mM b-mercaptoethanol, 0.1 mg/ml BSA and 25 mM MOPS-
NaOH, pH 7.2. Reactions, initiated by addition of 0.5 mlI Ni n
750 mM NaCl, 5 mM DTT and 10 mM Tris-HCl, pH 7.4 (DB),
were allowed to proceed for 1 h and were stopped by addition of
15 mM ethylenediaminetetraacetic acid (EDTA) and 0.3%
sodium dodecyl sulfate (SDS). Products, separated on denaturing
17% polyacrylamide gels, were visualized and quantified by
phosphor autoradiography using a Storm 860 imager. Strand
transfer reactions using pre-processed donor DNA were carried
out under the same conditions, except the 59-CAGTGTG-
GAAAATCTCTAGCA oligonucleotide was radiolabeled.
The concerted integration assay [50,69] used pGEM-9Zf(-) as
target and 59- end labeled 500-bp HIV-1 RU5 fragment [30] as
donor. Reactions (25 ml) contained 50–200 nM IN, 15 nM donor
DNA and 11 nM pGEM in 100 mM NaCl, 10 mM MgSO4,
5 mM DTT, 20 mM ZnCl2, 5% dimethyl sulfoxide (DMSO), 12%
polyethylene glycol (PEG) 6000 and 20 mM HEPES-NaOH,
pH 7.5. Reactions were started with the sequential addition of
donor DNA, target DNA, 1 ml IN in DB and 1.25 ml DMSO,
followed by a 2–4 min pre-incubation at room temperature before
addition of 6 ml 50% PEG6000. Reactions, incubated for 1 h at
37uC, were stopped by addition of 15 mM EDTA and 0.3% SDS.
The products, deproteinized by digestion with proteinase K and
precipitation with ethanol, were analyzed by electrophoresis
through 1.5% agarose gels in Tris-acetate buffer. Products were
visualized in dried gels using a Storm 860 imager (GE Healthcare).
The LEDGF-dependent concerted integration assay [30] used
blunt 32-bp donor DNA substrate, obtained by annealing
oligonucleotides 59-CCTTTTAGTCAGTGTGGAAAATCTC-
TAGCAGT and 59-ACTGCTAGAGA TTTTCCACACTGAC-
TAAAAGG, and supercoiled pGEM target. Reactions (40 ml)
contained 1 mM IN, 0.6 mM LEDGF, 0.6 mM donor DNA and
34 nM pGEM in 20 mM Hepes-NaOH pH 7.4, 10 mM DTT,
110 mM NaCl, 5 mM MgSO4 and 4 mM ZnCl2. Reactions were
initiated by the addition of 2 ml IN in DB, followed by a 10-min
incubation at room temperature, before addition of 2 ml LEDGF
in DB. Reactions were allowed to proceed for 30 minutes at 37uC
and stopped by addition of 25 mM EDTA and 0.5% SDS. DNAs
recovered by ethanol precipitation following deproteinization with
40 mg proteinase K for 1 h at 37uC were resolved by electropho-
resis through 1.5% agarose gels and detected by staining with
ethidium bromide.
HIV-1 infection
Single-round HIV-1 strain NLX.Luc.R- carrying luciferase in
place of nef (HIV-Luc) and either WT or D64N/D116N (N/N)
active site mutant IN was pseudotyped with vesicular stomatitis
virus G envelope glycoprotein as described [22,30,40]. WT or
mutant IN protein was incorporated in trans during virus assembly
by co-transfecting pRL2P-Vpr-IN plasmids [40]. Resulting cell-
free virus titers were determined by reverse transcriptase
incorporation of [a-
32P]TTP. HeLa-T4 cells [70] (40,000 in 12
well plates) infected in duplicate with 10
6 RT-cpm in 0.8 ml for
8 h were washed, lysed at 44 h post-infection, and luciferase
activities were normalized to total protein content. Levels of
virion-associated IN and capsid proteins were compared using
western blotting as described [71,72].
Sequence analysis of LEDGF/p75 cDNA from Ovis aries
GenBank entries EE831415 and EE774051, identified using
translated BLAST to span portions of Ovis aries LEDGF/p75
cDNA, were used to design oligonucleotide primers to isolate its
entire coding region. To this end, total RNA prepared from
phytohemagglutinin-stimulated sheep peripheral blood mononu-
clear cells was reverse-transcribed using Superscript III (Invitro-
gen) and gene-specific primer 59-CTATCAATTACACATTAA-
CATACACAC. A fragment spanning the entire coding region of
sheep LEDGF cDNA was PCR-amplified using EasyA DNA
polymerase (Stratagene) and primers 59-CCTGAAACAT-
GACTCGCGACTTCAAACC, 59-ACTTCTCAAATGTTC-
TTTATATTCCAGG. The sequence determined using a pool
of products from four independent amplification reactions was
deposited with GenBank with the accession number FJ497048
(RefSeq: NM_001143892).
Supporting Information
Figure S1 Amino acid sequence alignment of MVV and HIV-1
INs. Invariant residues are highlighted in bold print; residues
constituting the HHCC and D,D-35-E motifs are blue and red,
respectively. Blue triangles indicate HIV-1 IN residues targeted by
mutagenesis in this study. Residues involved in the interaction with
LEDGF are highlighted in pink, those involved in the intermo-
lecular NTD-CCD interface in cyan, and those participating in
the closure of the MVV IN tetramer in pale green; note that MVV
Tyr134 and HIV-1 Trp132 are both pink and cyan. NTD, CCD
and CTD spans are indicated, with the CCDs boxed. Residue
numbering above and below the alignment corresponds to the
MVV and HIV-1 sequences, respectively. Secondary structure
elements, shown atop the alignment, are numbered starting from
the beginning of each domain. Note that the CTD is not present in
the MVV structures. HIV-1 secondary structure was extracted
from PDB entries 1k6y and 1ex4. This figure was prepared using
ESPript (http://espript.ibcp.fr/).
Found at: doi:10.1371/journal.ppat.1000515.s001 (0.70 MB PDF)
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observed in CF1 (A–C) and CF2 (D). For each structure the
tetrameric chains are colored as in Figure 1 of the main text and
are aligned with respect to the green and cyan CCD dimer;
LEDGF chains are pink. Active site residues Asp66, Asp 118 and
Glu154 are indicated by red sticks. For the majority of inner
monomers, NTD-CCD connectivities are indicated by dashes.
The ordered NTD-CCD linker for CF1 chain B is shown as
backbone stick representation in panel C.
Found at: doi:10.1371/journal.ppat.1000515.s002 (5.39 MB PDF)
Figure S3 Cross-linking experiments. WT (lanes 1–4), E11K
(lanes 5–8), or K186E (lanes 9–12) HIV-1 IN (3 mM), or a mixture
of the E11K and K186E mutants (1.5 mM each) (lanes 13–16)
were incubated with 2 - 0.2 mM BS
3, in the presence (lanes 1, 5, 9,
13) or absence of 0.3% SDS, as indicated. The reaction products,
resolved in SDS PAGE gels, were detected by staining with Sypro
Orange. Positions of molecular weight markers are indicated to
the left of the gel image. To the right of the gel migration positions
of the tetramers as well as the products of partial cross-linking
(monomers, dimers, and trimers) are shown. The gel is shown in
reverse contrast.
Found at: doi:10.1371/journal.ppat.1000515.s003 (3.96 MB PDF)
Figure S4 Composite model of a full-length HIV-1 IN tetramer
in closed conformation. The model was obtained by superposition
of partial HIV-1 INNTD+CCD (PDB ID 1k6y) and INCCD+CTD
(PDB ID 1ex4) structures onto the INNTD+CCD tetramer observed
in CF2 (Figure 1C, Figure S2D). The CCDs and inner NTDs are
colored as in Figure 1, LEDGF chains are omitted for clarity. The
outer NTDs belonging to the green and orange IN chains are
shown pale green and pale orange, respectively. The CTD regions
derived from HIV-1 INCCD+CTD are gray. Note that the CCD-
CTD linker region, here shown in alpha helical conformation, is
flexible (see main text for more discussion) and is likely to adopt a
different conformation in the context of the full-length protein.
Four orientations of the model, related by 90u rotations, are
shown. The orientation on the top left is identical to that of the
CF2 tetramer in Figure 1C. The lower right inset shows a
magnified view of the dimer-dimer interface, with residues Ile191
and Tyr194 shown as sticks. The other inset magnifies the
potential target DNA binding face, with Ser119 and Glu152
residues from the inner monomers highlighted. Red triangles mark
the scissile phospodiester bonds across the major groove.
Found at: doi:10.1371/journal.ppat.1000515.s004 (3.43 MB PDF)
Figure S5 Examples of weighted 2Fo-Fc electron density maps
for the refined structures. (A) IN chain B in CF1. Electron density,
displayed as chicken wire, is colored blue for the NTD-CCD linker
region (residues 44–61) and gray for the rest of the chain. The
protein is shown as sticks and semitransparent cartoon. The NTD,
CCD and linker are indicated. (B) The interface involving chain C
NTD and the AB CCD dimer in CF2. (C) The interface of
LEDGF chain E with AB CCD in CF2. (D) Active site of IN chain
B with an associated phosphate ion in CF2. Note that a phosphate
ion has been observed in a structurally identical position in two
HIV-1 IN structures (PDB IDs 1k6y and 2b4j). The map in panel
A is contoured at 1s and those in panels B–D at 1.2s. Carbon
atoms are colored by chain as indicated in the legends to the right,
and other atoms are colored blue for nitrogen, red for oxygen,
yellow for sulfur, or orange for phosphorus. The gray sphere is
zinc; red spheres are water molecules.
Found at: doi:10.1371/journal.ppat.1000515.s005 (9.87 MB PDF)
Video S1 Simulation of transitions between the open and closed
conformations of the MVV IN tetramer (side view). Experimen-
tally determined structures CF1/CDEF, CF1/ABEF and CF2
correspond to the first, middle and the last frames of the
animation, respectively. IN chains are shown as cartoons; residues
discussed in the main text are shown in ball-and-stick style. The
color code is preserved from Figure 1 of the main text. Running
numbers show separation of the active sites (measured as distance
between Cc atoms of Glu154 residues in cyan and yellow chains).
Asp66, Asp118 and Glu154 in the inner monomers are collectively
indicated as DDE motifs. Residues 148–151 from the inner
monomers (cyan and yellow) are omitted for clarity. Note a slight
deformation of a4 helices and compression of the active sites
towards the end of the animation. Transitions states were
interpolated using Yale Morph Server (http://molmovdb.org/),
and the movie was created with PyMOL (http://pymol.source-
forge.net/).
Found at: doi:10.1371/journal.ppat.1000515.s006 (4.83 MB
MOV)
Video S2 Simulation of transitions between the open and closed
conformations of MVV IN tetramer (view from top). Same as in
Video S1, with the tetramers viewed from top, as in Figure 1 of the
main text.
Found at: doi:10.1371/journal.ppat.1000515.s007 (4.97 MB
MOV)
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